FDA Investigator Jonathan A Womack

Jonathan A Womack has conducted inspections on 164 sites in 2 countries as of 01 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
164
Last Inspection Date:
01 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Thailand
FDA Investigators that have inspected at least one site in common with Jonathan A Womack:
Adam C Hipko, Adrian Rodriguez, Alanna L Mussawwir Bias, Alcee M Tavarez, Alfredo Iniguez Garcia, Andrew J Lang, Angela Mock, Angele C Smith, Anh M Lac, Arie R Dyk, Ashley N Williams, Axel M Ambert, Benjamin P Stewart, Betsy C Galliher, Bing Lin, Brackens Harris, Brandon K Barbee, Brenda G Stewart Munoz, Brook Shea, Camille D Brown, Casey L Hamblin, Cassandra L Abellard, Cathleen A Castellaw, Chad J Whitwell, Charles B Steinmiller, Charles D Brown, Christopher D Rush, Christopher J Hurst, Christopher J Smith, Christopher K Gibbs, Christopher L Jacobs, Christopher T Peters, Coleen L Manoy, Connie L Hannon Rabel, Constance M Dobbins, Crystal S Harris, Cymbre Weatherly, Dallas E Gilbreath Jr, Dana M Lewis, Daniel J Lahar, Daniel S Fam, Danielle Lyke, Danny D Horner, Deborah K Richardson, Debra L Curtis, Denise Connelly, Deniza Karacic, Dirk L Lincoln, Douglas J Snyder, Ed Gonzalez Vazquez, Elisa M Fleming, Elizabeth D Connell, Elmina E Akwo, Elmina E Mboh, Elvia J Cervantes, Ernest Serna, III, Fernando C Martinez, Florecia S Philogene, Frans E Mercado, Gatica, Gery M Duparc, Glasgow Glasgow, Grant L Davis, Gregory A Holt, Habacuc V Barrera, Hala L Selby, Haley L Coleman, Huanli Liu, Hung V Le, Iris C Macinnes, J Elkins, Jacey Roy, Jacob W Reynolds, Jamie M Bumpas, Jane M Broussard, Janice M Hickok, Jay O Gibson, Jeffrey R Wooley, Jennifer D Young, Jennifer Hua, Jennifer O Dowdy, Jeremi S Mullins, Jeremy L Stukes, Jodi M Gatica, Johnson, Juan D Lopez, Kamara Tx, Karlton T Watson, Kathleen Chmura Shaffer, Katlin N Stubbs, Kayla R Deatherage, Keegan B Mixon, Kelly C Ely, Kelvin R Wright, Kenitra D Hewitt, Kunapuli T Madhusudhan, L B Booty, L Grant, Lance D Johnson, Latorie S Jones, Lauren E Skokan, Lauren M Lilly, PhD, Lauren R Brady, Lauren R Howell, Leighton Kn Gai, Lisa M Puttonen, Lisa R Jennings, Liza L Quiles, Lloyd D Payne, Loan T Tran, Lorie S Hannappel, Lourdes R Genera, Marc Balzarini, Marc R Dickens, Marcia G Evans, Margaret M Annes, Margarito J Uribe, Mariana F Baxter, Marlena C Freeman, Martha S Baldwin, Massoud Motamed, Merelynn Rhoten, Michael A Nordos, Michael L Jones, Michelle A Krayer, Michelle C Webb, Micmarie Ramos Rodriguez, Monique Rac Lester, Monique S Frazier, Natasha N Livingston, Nimmy Mathews, Patty P Kaewussdangkul, Paul E Frazier, Paula J Perry, Pauline N Logan, Payne, Phillip J Sample, Quynh Anh H Tran, Rendall E Barfoot, Robert T Harris, Robert T Lorenz, Roy Baby, Sabino S Camacho, Saijal P Naik, Samuel A Hamblin, Samuel R Carter, Sandy J Ziegler, Sara A Valenzuela, Scott A Hendrix, Scott T Ballard, Selina M Mata, Seri L Essary, Shannon A Lowe, Shawn E Larson, Staci G Mcallister, Tamera H Hunt, Tara A Gray, Terren L Cheesbro, Thomas B Smith, Timothy B Webb, Toby Vern H Hill, Torrance J Slayton, Tracy J Washington, Travis S Brown, Tricia S Martinez, Trina K Vick, Verlinda A Narcisse, Vitaliy N Guyvan, Yaw O Osei, Young M Yoon

Jonathan A Womack's Documents

Publish Date Document Type Title
August, 2019 FDA 483 Texas Tripe - Form 483, 2019-08-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more